New Medicare Bill Provides Benefits to Lupus Patients in Prescription Drug Program

Congress voted overwhelmingly July 16 to override a Presidential veto forcing enactment of HR 6331, the Medicare Improvements for Patients and Providers Act. The legislation makes changes favorable to lupus patients receiving benefits through the Medicare “Part D” prescription drug program.